SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Patel Ajay

(Last) (First) (Middle)
C/O ASSERTIO HOLDINGS, INC.
100 SOUTH SAUNDERS ROAD, SUITE 300

(Street)
LAKE FOREST IL 60045

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/11/2021
3. Issuer Name and Ticker or Trading Symbol
Assertio Holdings, Inc. [ ASRT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP and CAO
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 34,123 D
Common Stock 6,000(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (2) 07/31/2022 Common Stock 64,480 0.0 D
Restricted Stock Units (3) 02/04/2023 Common Stock 39,864 0.0 D
Restricted Stock Units (4) 02/11/2024 Common Stock 568,182 0.0 D
Explanation of Responses:
1. Shares purchased pursuant to the Issuer's Employee Stock Purchase Plan (the "Plan"). In accordance with the Plan, 3,000 shares were purchased on May 31, 2020 at $0.65 per share and 3,000 shares were purchased on November 30, 2020 at $0.36 per share.
2. One-third of these restricted stock units are scheduled to vest on each of July 31, 2020, 2021 and 2022, assuming continued employment through the applicable vesting date.
3. One-third of these restricted stock units are scheduled to vest on each of February 4, 2021, 2022 and 2023, assuming continued employment through the applicable vesting date.
4. One-third of these restricted stock units are scheduled to vest on each of February 11, 2022, 2023 and 2024, assuming continued employment through the applicable vesting date.
Remarks:
/s/ Jennifer Hipelius, attorney in fact for Ajay Patel 03/22/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Exhibit 24.1

POWER OF ATTORNEY
Assertio Holdings, Inc.

    The undersigned hereby constitutes and appoints Sam Schlessinger, Jennifer Hipelius and
Paul Schwichtenberg, individually, as the undersignedTMs true and lawful attorney-in-fact to:

(1) execute and deliver on behalf of the undersigned, in the undersignedTMs capacity as an
officer and/or director of Assertio Therapeutics, Inc., a Delaware corporation (the
Company), any and all documents relating to insider reporting requirements under
Section 16 of the Securities Exchange Act of 1934, including, without limitation, the
execution and filing of all Forms ID, 3, 4 and 5 (collectively, the Section 16 Filings),

(2) do and perform any and all acts for and on behalf of the undersigned which may be
necessary or desirable to complete and execute any such Section 16 Filings, complete and
execute any amendments thereto, and timely file such form with the United States
Securities and Exchange Commission and any stock exchange or similar authority; and

(3) take any other action of any type whatsoever in connection with the foregoing which, in
the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally
required by, the undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be
in such form and shall contain such terms and conditions as such attorney-in-fact may
approve in such attorney-in-factTMs discretion.

    The undersigned hereby grants to the attorney-in-fact full power and authority to do and
perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the
exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-
factTMs substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of
Attorney and the rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not
assuming, nor is the Company assuming, any of theundersignedTMs responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.

    This Power of Attorney shall remain in full force and effect until the undersigned is no
longer required to file Section 16 Filings with respect to the undersignedTMs holdings of and
transactions in securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.

    IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 26th day of February 2021.

/s/ Ajay Patel
__________________________
Ajay Patel